US Patent Issued to Fresenius Medical Care Deutschland on June 10 for "Method and devices for determining a treatment regimen for altering the treatment parameters when dialyzing a patient" (German Inventor)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,875, issued on June 10, was assigned to Fresenius Medical Care Deutschland GmbH (Bad Homburg, Germany).

"Method and devices for determining a treatment regimen for altering the treatment parameters when dialyzing a patient" was invented by Andreas Maierhofer (Schweinfurt, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determining a treatment regimen for altering the treatment parameters when dialyzing a patient over a plurality of treatment sessions taking place on future days includes determining a diffusive total target sodium balance; and determining a transitional treatment regimen by which the diffusive total target sodium ...